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physiology. In the second place mathematical models are 
special in that there is hardly a limit to the complications 
that can be introduced. Until the sixties of the last cen-
tury the numerical solution of the mathematical formula 
that describe ‘stiff’ differential equations was an unre-
solved problem. Stiff differential equations describe phe-
nomena that play on widely different time scales. The 
Michaelis-Menten model is an example: there the en-
zyme-substrate complex forms at the millisecond scale, 
whereas the formation of the product occurs on the min-
ute-, or even hour-scale. The development of variable step 
length techniques together with the increase of computer 
power on our desks has solved this problem in the mean-
time. Nowadays chemical systems of any reasonable com-
plexity are readily simulated. The partial differential 
equations that resolve the development of concentration 
changes in time and space, and especially that consider 
ﬂ ow of blood (which is, from a physical point of view, 
rather complex and heterogeneous non-Newtonian ﬂ uid), 
may still stress the capacity of our computing systems, 
though. 
 The possibility to simulate more and more compli-
cated systems, indeed so complicated as to incorporate 
almost all of the known reactions of the clotting system, 
comes at a price. By complete analogy with experimental 
models, increasing complexity and completeness may 
 Modeling means replacing a complicated mechanism 
by a simpler one that is more easy to understand and/or 
to manipulate. The complexity of the hemostatic and 
thrombotic system (H&TS) is such that it is impossible 
to understand without modeling. The Quick-time is a 
model of the downregulation of the H&TS by oral anti-
coagulation or liver disease. The bleeding time is another 
model of another subsystem of the H&TS, with another 
scope. This illustrates that models never are complete and 
that they do not need to be complete to be useful. Actu-
ally, the most complete models are usually also complex, 
time-consuming, expensive, and extremely difﬁ cult to in-
terprete. 
 Mathematical models are of a special kind (for a re-
view of mathematical and computer research in coagula-
tion, see  [1] ). In the ﬁ rst place they are impressive and 
impenetrable to the noninitiated – and the initiated are 
few. The biological scientist as a rule is not familiar with 
this approach. As soon as a biochemical mechanism is 
more complicated than the Michaelis-Menten model of 
enzyme action, many life-scientists and clinicians tend to 
be turned off, which is a pity because mathematical mod-
eling is not an aim in itself, but should prove its value in 
the confrontation with actual laboratory data and needs 
the biologists for its veriﬁ cation. This is one reason to 
broach mathematical modeling in a journal on patho-
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lead to negative effects. The way in which a mathematical 
solution is found becomes a black box for the laboratory 
scientist and special efforts are needed to make sure that 
there is a reasonable connection between what you put 
into it (reaction mechanisms and parameters) and what 
you get out of it (relations that look like experimental re-
sults) – we will come back to that point.  
 In the third place mathematical simulation, fascinat-
ing though it is to the addicted, cannot be an aim in itself. 
In the end it should be rigorously proven to be relevant 
to the biological situation. Therefore, any simulation ex-
periment should go through three stages. The ﬁ rst stage 
is the ‘what if’ stage, it is the most imaginative, not to say 
the artistic part. The investigator imagines a plausible 
reaction mechanism and asks the question: what if this 
mechanism were operative in reality, how would it re-
spond to variations in its different parameters? How 
would a model of thrombus growth react to halving the 
concentration of prothrombin? Or to an increase of the 
ﬂ ow velocity? The larger part of the articles in the present 
volume are dedicated to this fascinating game. They ana-
lyze and predict effects of ﬂ ow  [2–5] , diffusion  [4, 5] , ves-
sel wall thrombomodulin  [4] , and chemical inhibitors  [3] 
on the coagulation processes (clotting initiation  [3, 4] , 
pattern formation  [2] , propagation  [3–5] , shear stress pro-
ﬁ le, and lysis  [5]) . 
 The next step is the confrontation with the reality of 
the ‘wet’ experiment: can the model indeed quantitative-
ly explain the experimental data? Is it possible to ﬁ t the 
simulated curves to experimental results within the limits 
of experimental error? This step requires close coopera-
tion between the biochemist and the mathematician, spe-
cialized in curve-ﬁ tting, a branch of numerical mathe-
matics. For example, a paper by Jesty et al.  [6] focuses on 
the activation threshold in the contact activation path-
way: theory and experiments are combined to show that 
a system with an autoactivating enzyme (factor XIIa) in 
the presence of an irreversible inhibitor (antithrombin 
III) has an activation threshold. An example of fruitful 
combination of stochastic simulation and thrombin gen-
eration experiments can also be found in the study by Lo 
et al.  [7] . 
 Lack of agreement between experimental and simu-
lated data can be an important source of information in 
itself, indicating some gaps in our knowledge of the stud-
ied system, as is also illustrated by the study  [7] .  
 Only after an acceptable ﬁ t between the model and 
experimental data is obtained, comes the apex stone of 
the construction, the most crucial part and consolidation 
of the enterprise, because it then remains to be proven 
that the postulated mechanism is indeed operative in ex-
perimental reality. It may come as an unpleasant surprise, 
but it is quite possible that the same experimental curve 
can be explained by a large series of equally plausible 
mechanisms. A ﬁ t between experimental and simulated 
data does not at all mean that the assumptions underlying 
the simulation are right! 
 As soon as the number of parameters that are used to 
characterize the model system is much larger than the 
number of parameters that characterize the output, there 
usually are multiple ways to achieve the same ﬁ t. For ex-
ample, the thrombin generation curve rises and falls after 
a given lag time. This type of relatively simple curve can 
be described by less than ten parameters. In a realistic 
simulation experiment it is the result of the complete clot-
ting mechanism, which needs some eighty concentrations 
and reaction constants to be deﬁ ned. It stands to reason 
that there are multiple ways to use eighty input parame-
ters to get ten output parameters. Multiple variations of 
the reaction mechanism, but also multiple sets of con-
stants within the same reaction mechanism will yield the 
same result. Decreasing the prothrombin content by 25% 
in a thrombin generation experiment can be compensat-
ed for by decreasing the antithrombin content as well. 
Two curves can result that are indistinguishable. Of 
course, it is possible to perform numerous experiments 
under various conditions (titrating tissue factor, pro-
thrombin, antithrombin III, etc.) using a single set of 
model parameters and to obtain agreement between the 
model and multiple experimental curves. Actually, this 
way of validation is the one that should be and, some-
times, is used, but it still does not completely guarantee 
validity of the model. The number of ﬁ ts is always ﬁ nite, 
and the majority of system parameters cannot be experi-
mentally changed for such veriﬁ cation (e.g., we can change 
prothrombin concentration to test whether it is accurate-
ly included in the model but it is very hard to change a 
prothrombin activation constant). 
 In this stage of simulation it is therefore good mathe-
matical practice to investigate how far a solution that is 
found is indeed unique. If the curve ﬁ tting is done in a 
professional way, the outcome will not be a set of param-
eters by which the system will yield a ﬁ tting curve, but a 
set of multifolds, formulas that describe combinations of 
parameters that all will give a ﬁ tting curve. 
 In hemostasis and thrombosis, mechanisms that are 
realistic are so large that they seldom are unique, and a 
lot of reasonable alternatives are usually possible. Mech-
anisms that are unique are so simple that they are not 
realistic, just as the Michaelis-Menten model of enzyme 
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action is much simpler than the catalytic mechanisms 
that we know to be operative, even in the simple conver-
sion of one simple substrate by a simple enzyme. 
 It is an old saying among mathematicians that you can 
ﬁ t an elephant with ﬁ ve parameters and make it wig its 
tail with the sixth. The science of simulation can be read-
ily used to simulate science. This is not to say that serious 
simulation is not a valuable tool. It only says that its use 
requires good mathematical practice and, in the end, pro-
found confrontation of the data from the experiments ‘in 
silico’ and ‘in solutio’. 
 Conclusion 
 Simulation comes in three steps: ﬁ rst, imagination of 
a suitable system; second, confrontation with the reality 
of experimental outcome; and third, consolidation of the 
conclusions by exclusion of alternatives. Together, this is 
a formidable task when the system is as large as the H&TS 
is. This task requires close cooperation between the math-
ematically inclined and the laboratory. The articles in this 
volume are an important step in achieving such coopera-
tion. 
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